A case of granulomatous rosacea coinciding with the use of etanercept. No relapse with infliximab;Ein fall von granulomatöser rosazea im zeitlichen zusammenhang mit etanercept. Kein rezidiv unter infliximab

Hautarzt

Volumn 59, Issue 9, 2008, Pages 724-727

  Winter, U M ^a   Treudler, R ^a   Paasch, U ^a   Sticherling, M ^b   Simon, J C ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Adverse drug reaction; Etanercept; Infliximab; Psoriasis; Rosacea

Indexed keywords

ETANERCEPT; INFLIXIMAB;

ARTICLE; CELL INFILTRATION; DISEASE EXACERBATION; DRUG EFFECT; DRUG WITHDRAWAL; HISTOPATHOLOGY; HUMAN; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; ROSACEA; T LYMPHOCYTE; TREATMENT OUTCOME;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; DERMATOLOGIC AGENTS; FEMALE; HUMANS; IMMUNOGLOBULIN G; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; RECURRENCE; ROSACEA; TREATMENT OUTCOME;

EID: 51549109135     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-008-1533-z     Document Type: Article

References (11)

1. Cabou C, Bagheri H, Cantagrel A et al. (2003) Retrospective analysis of adverse effects of infliximab in a hospital rheumatology service. Therapie. 58(5): 457-462
2. Deng 2006 Arch Dermatol 142 198
3. Lee 2007 Br J Dermatol 156 486
4. Wallis 2005 Clin Infect Dis 1 S194
5. Furst 2006 Semin Arthritis Rheum 36 159
6. Wallis 2005 Semin Arthritis Rheum 34 34
7. Mathieu 2007 Joint Bone Spin 74 184
8. Beenhouwer 2004 J Rheumatol 31 1888
9. Wallis RS et al. (2004) Granulomaous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis. 1;38(9): 1261-1265
10. Verschueren 2007 Clin Rheumatol 26 1969
11. Bachmeyer 2007 J Eur Acad Dermatol Venerol 21 550